Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First in Human (FIH) Study for the Evaluation of the Safety and Early Performance of the Vibe Delivery System for the Delivery of Botox™ in Subjects With Idiopathic Overactive Bladder (OAB)

NCT03874780 is registered in ClinicalTrials.gov with Vensica Therapeutics Ltd. as lead sponsor.

NCT NCT03874780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03874780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First in Human (FIH) Study for the Evaluation of the Safety and Early Performance of the Vibe Delivery System for the Delivery of Botox™ in Subjects With Idiopathic Overactive Bladder (OAB)
Lead sponsor
Vensica Therapeutics Ltd.
Phase
Not applicable
Overall status
Completed
Start date
January 29, 2019
Completion date
March 31, 2019
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder